Antivirals 2000 – and what Next?
Authors:
A. Holý
Authors‘ workplace:
Ústav organické chemie a biochemie AV ČR, Praha
Published in:
Čas. Lék. čes. 2001; : 583-591
Category:
Overview
The present situation in the antiviral chemotherapy is discussed from the point of view of drugs available fortreatment of the most important human pathogens. While the existing battery of approved drugs is aimed mainly atthe therapy of AIDS, there are several drugs available for treatment of diseases caused by DNA viruses (herpesviruses,hepatitis B). The prospect is much worse in the therapy of infections caused by RNA viruses except for the recentlyapproved anti-influenza preparations. Drugs in clinical development are aimed at enteroviruses and hepatitis C, aswell as at resistant mutants of HIV, HBV and VZV.
Key words:
chemotherapy, viral diseases, DNA viruses, RNA viruses, AIDS, antivirals.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Antimicrobial Chemotherapy – Are we Really at the End of Antibiotic Era?
- Present Situation and Perspectives of Antimycotics with Systemic Effect
- Antivirals 2000 – and what Next?
- Biological Principle of Chemotherapy: Cellular Response – the Result of its Evolutional Memory